NeuroPace — responsive epilepsy neurostimulation
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Steve Cohen / Point72 | 75 | New buy | 28,843 | $396,880 | 0.0% |
| Paul Tudor Jones / Tudor | 61 | Added +30% | 143,233 | $1,970,886 | 0.0% |
| Report | Date | Stance |
|---|---|---|
| #80 — Market Memo: January Musings | 2025-01-09 | LONG |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-11-17.